Qu Biologics Welcomes Dr. Richard Fedorak and Dr. William Sandborn to Newly Formed IBD Advisory Team for Crohn's Disease Clinical Trial
30 mai 2013 13h43 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 30, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics Launches Treatment Trial for Crohn's Disease
07 mars 2013 06h30 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 7, 2013) - Canadian participants are being sought for a new Health Canada-approved clinical trial for the treatment of Crohn's disease,...